| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Alzheimers disease 0.5178007277072818 3.049049224611448 0.0022956686311628 0.7464234952851014 0.0351413890462615 88 P21796,P49721,P45880,P31751,Q9BVA1,Q9Y277,Q13885,P04350,Q92542,P31749,P20618,Q9BUF5,P28072,P07437,P16615,P27361,Q9NQC3,O95197,P68371,P14735 20 |
| Alzheimers disease and mirna effects 0.5100323839366253 2.983425678133657 0.0028504125361101 0.8180687063905626 0.039015394165187 89 P21796,P49721,P45880,P31751,Q9BVA1,Q9Y277,Q13885,P04350,Q92542,P31749,P20618,Q9BUF5,P28072,P07437,P16615,P27361,Q9NQC3,O95197,P68371,P14735 20 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.6982449834154615 2.922116351857963 0.0034766163780681 0.8749643384498043 0.0441604250575893 24 Q14739,Q15800,P37268,Q15125,Q15392,Q9BWD1,P48449,Q14534,Q16850,O95864,P14324 11 |
| Electron transport chain oxphos system in mitochondria 0.524888127729727 2.556905376302217 0.0105607940521963 0.9982327350072068 0.112585608020736 49 P20674,P00403,P24539,O75880,Q9Y6M9,O75964,P13073,P03886,O43678,O95168,P14406,Q7KZN9,O75306,Q9UDW1,O14949,O43676,P00846 17 |
| Nonalcoholic fatty liver disease 0.5027783955787888 2.349991123888435 0.0187738587538131 0.9999878056511958 0.1932412702763176 48 P20674,Q07812,P00403,O96000,P54646,P31749,P13073,Q9Y6M9,O43678,O95168,P31751,Q86Y39,P14406,P05198,O75306,Q9UDW1,O14949,O43676 18 |
| Degradation pathway of sphingolipids including diseases 0.8848944591028913 2.339232021675842 0.019323428678619 0.9999912722440552 0.1955268969683992 7 P06865,O43681,P16278,P07686,P17900,P06280 6 |
| Sphingolipid metabolism overview 0.855264716313433 2.33218161928736 0.0196911387103881 0.9999930230078418 0.1959268301683625 8 P27544,Q13510,Q16739,Q96G23,O95470,Q06136 6 |
| Sphingolipid metabolism integrated pathway 0.825918011818318 2.324492732473847 0.0200991006276245 0.9999945581408805 0.196707591388391 9 P27544,Q13510,Q16739,Q96G23,O95470,Q06136,O15269 7 |
| Pathogenic escherichia coli infection 0.6040483243218252 2.3075142181917903 0.0210261705306906 0.9999969073125484 0.1992479969336877 23 Q13885,P07437,P04350,Q9BVA1,P68371 5 |
| Mitochondrial complex iv assembly 0.8190346041768061 2.293436520426008 0.0218228860954383 0.9999980978443972 0.2008409335779626 9 P20674,P00403,P14406,Q7KZN9,Q9Y2R0 5 |
| Drug induction of bile acid pathway 0.965097135330918 2.292668396973056 0.0218671033208837 0.9999981484917976 0.2008409335779626 2 Q06520 1 |
| Sphingolipid metabolism in senescence 0.7734075667567024 2.255966141663141 0.0240727516577692 0.9999995189236656 0.2053883721949901 11 Q13510,Q16739,P04062,Q96G23,P16278,Q06136,O15269 7 |
| Glycosaminoglycan degradation 0.9386947923533258 2.2449637942381098 0.0247704569481395 0.9999996861017452 0.2053883721949901 5 P16278,P54802,P06865,P07686 4 |
| S1p receptor signal transduction 0.8581178923636501 2.224866783711884 0.0260901824643156 0.9999998601411234 0.2104843098810326 7 P31749,P27361,Q13510 3 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8823216037471003 2.21078446097979 0.0270507663988619 0.999999922404302 0.2153241005349411 6 Q15125,Q14739,Q16850 3 |
| Sphingolipid pathway 0.7660978892072595 2.1329527457851207 0.0329286027920738 0.9999999979167208 0.2553035826865988 10 Q13510,Q16739,P04062,Q96G23,O95470,Q06136,O15269 7 |
| Neovascularisation processes 0.9222917352650633 2.1097080994411677 0.0348835064261008 0.9999999993775516 0.2574467314006636 2 P31749 1 |
| Ciliopathies 0.5951912497005964 2.107424299719953 0.03508081711086 0.9999999994490764 0.2574467314006636 19 Q13432,O43924,O75695 3 |
| Metapathway biotransformation phase i and ii 0.5745868682407835 2.1039067976918746 0.0353865779061948 0.9999999995440466 0.2574467314006636 22 Q9H0A0,Q8NCH0,P07099,Q16850 4 |
| Vitamin a and carotenoid metabolism 0.915377016792884 2.079901242260327 0.037534592072745 0.999999999879518 0.2653765596692302 2 Q8WTV0 1 |
| 7oxoc and 7betahc pathways 0.7677529359354023 2.058468116770403 0.039545218808356 0.999999999965428 0.2716996549663939 9 Q15125 1 |
| Mitochondrial complex i assembly model oxphos system 0.5659504729533329 2.0579553253418807 0.0395944220805297 0.9999999999664696 0.2716996549663939 24 P03886,O43678,O95168,O75306,Q9Y6M9,Q96CU9,O43676 7 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.844484525006528 2.051130454561513 0.0402542442392033 0.999999999977754 0.272108242177421 6 P07099,P09601 2 |
| Mecp2 and associated rett syndrome 0.6177169112508359 2.022355162551385 0.043139673639065 0.9999999999963136 0.2725420923113612 17 P31749,Q08211,P52597,P35637,P31943 5 |
| Ferroptosis 0.5554444142157109 1.9926724910161575 0.0462973215561275 0.9999999999994876 0.2850863399635833 25 P45880,P37268,Q6P1A2,P09601,Q96QD8,P16435 6 |
| Relationship between inflammation cox2 and egfr 0.9116968698517296 1.9924604441749876 0.0463205610996106 0.9999999999994952 0.2850863399635833 4 P31749,P31751,P27361 3 |
| Zinc homeostasis 0.8867303259795805 1.955719782771966 0.0504981729937155 0.9999999999999633 0.2984892007648332 2 Q92504 1 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.7674247103426416 1.93974856245372 0.0524102546245102 0.999999999999989 0.3067541373611039 8 P61020,P31943,P27361,P20339 4 |
| Urea cycle and related diseases 0.8775107013500116 1.9155274271685772 0.0554252747977335 0.9999999999999984 0.3108371485434085 2 Q9UJS0 1 |
| Metabolism of spingolipids in er and golgi apparatus 0.8856672158154826 1.8894229943106065 0.0588351721698579 0.9999999999999998 0.3108371485434085 4 Q10472,Q16739,O95470 3 |
| Oxidation by cytochrome p450 0.8480698299566325 1.877129639483668 0.060500327980943 1.0 0.3168306649528334 5 O43169,Q16850 2 |
| Cholesterol biosynthesis pathway 0.6504991734803991 1.8142606826545369 0.0696376016316699 1.0 0.3493583880177057 13 Q15800,P37268,Q16850,Q14534,P14324 5 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.8284844759199508 1.7959740911751991 0.0724986376664245 1.0 0.3606807223904619 5 P09601 1 |
| Arachidonate epoxygenase epoxide hydrolase 0.8449127428383176 1.772632494324376 0.0762896236528147 1.0 0.3698890859605286 2 P20674 1 |
| Proteoglycan biosynthesis 0.9370882740448004 1.769395573296025 0.076827883851098 1.0 0.3698890859605286 3 Q8TB61,Q8NCH0 2 |
| Mitochondrial complex iii assembly 0.7271648753811983 1.7543215916839423 0.0793754180783714 1.0 0.3760882904189505 8 O14949,Q9Y276,Q9UDW1 3 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.8467367452905687 1.7336881851354595 0.0829734239785515 1.0 0.3820859266432723 4 O00584 1 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.8464779725161888 1.7326469460090106 0.0831584396594951 1.0 0.3820859266432723 4 P31749,P27361 2 |
| Vitamin d receptor pathway 0.6513397504189617 1.7307293249300737 0.0835000523904256 1.0 0.3820859266432723 12 Q06520,P08183,Q96KA5,Q92783 4 |
| Ccl18 signaling pathway 0.6795731257007055 1.713635935291103 0.0865956094989834 1.0 0.3895347624018245 10 P00403,P08670,P11166 3 |
| Adipogenesis 0.5982979722611624 1.7126292085926604 0.0867807762134718 1.0 0.3895347624018245 15 O75844,P43490 2 |
| Endothelin pathways 0.7635708514989242 1.7011655145393965 0.0889119114785876 1.0 0.3897221148698799 6 P00403,P42892 2 |
| Statin inhibition of cholesterol production 0.8367125618500322 1.6932989817479622 0.0903985718597433 1.0 0.3897221148698799 4 Q8WTV0,Q14534 2 |
| Mitochondrial immune response to sarscov2 0.6810842998055853 1.64726634835134 0.0995033115732828 1.0 0.4074319412112687 9 Q86UT6,Q9Y276 2 |
| Familial hyperlipidemia type 1 0.815607507408624 1.6432924590575662 0.1003224377856826 1.0 0.4074319412112687 2 Q9UBV2 1 |
| Familial hyperlipidemia type 5 0.815607507408624 1.6432924590575662 0.1003224377856826 1.0 0.4074319412112687 2 Q9UBV2 1 |
| Familial hyperlipidemia type 3 0.8156075074086169 1.643292459057534 0.1003224377856892 1.0 0.4074319412112687 2 Q8WTV0 1 |
| Pregnane x receptor pathway 0.7872705548876069 1.623510376845969 0.1044803469247142 1.0 0.4158317807603625 5 Q06520 1 |
| Joubert syndrome 0.5202482588041368 1.6159812660833843 0.1060983636592898 1.0 0.4180080136354405 19 Q13432,O43924,O75695 3 |
| Familial partial lipodystrophy fpld 0.6743167702278243 1.614460855461039 0.1064275009591071 1.0 0.4180080136354405 9 Q96AD5,O75844,O60725 3 |
| Rac1pak1p38mmp2 pathway 0.5800605766456147 1.6062821457171308 0.1082119314440492 1.0 0.4194969030655677 15 Q07812,P55210,Q16539,P31749,P27361,P35222 6 |
| Kisspeptinkisspeptin receptor system in the ovary 0.7799341905285708 1.5925953343765444 0.1112510008778169 1.0 0.425749022590107 5 P31749,P27361 2 |
| Ketogenesis and ketolysis 0.7772460881748087 1.5812532101979553 0.113820153333819 1.0 0.4300672882296832 5 P23786,O43772,P11166 3 |
| Cell migration and invasion through p75ntr 0.7225804908288919 1.5199812625023148 0.1285156849866164 1.0 0.4649931147697578 6 P31749,P31751 2 |
| Alpha 6 beta 4 signaling pathway 0.6989140547931626 1.515976549481296 0.1295252822095789 1.0 0.465822852283847 7 Q16539,P31749,P27361,P42345,O00459 5 |
| Eicosanoid synthesis 0.8606969738372905 1.4710734470923796 0.1412712550494546 1.0 0.4959425970751377 3 P09960 1 |
| Transcription factor regulation in adipogenesis 0.7754362858083608 1.4651330017384154 0.1428846343332055 1.0 0.4959425970751377 2 P04150 1 |
| Hepatitis c and hepatocellular carcinoma 0.6269166909118709 1.4499005294488667 0.147086259690317 1.0 0.4981876714485367 10 P55210,Q16539,P31749,P31350,P27361 5 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.6405025539785534 1.4492332609619392 0.1472724518151833 1.0 0.4981876714485367 9 P27361,P31749,P31751 3 |
| Triacylglyceride synthesis 0.7762545276042573 1.447689590416297 0.1477038824897671 1.0 0.4981876714485367 4 Q96AD5,O00116 2 |
| Vitamin d metabolism 0.8518381834191744 1.4362945361724448 0.150918548137092 1.0 0.5025914165633083 3 P04062 1 |
| Phosphodiesterases in neuronal function 0.8517311787029399 1.4358743401129523 0.151038101259205 1.0 0.5025914165633083 3 O43924 1 |
| Parkinubiquitin proteasomal system pathway 0.4439752312395181 1.40655697181815 0.1595587996923242 1.0 0.5097016077926666 35 Q13885,P07437,P04350,Q9BVA1,P68371 5 |
| Spinal cord injury 0.5037312961250008 1.406231890023245 0.159655277482795 1.0 0.5097016077926666 18 P08670,P24941,P27361,P14174,P62942,Q9NQC3 6 |
| Bile acids synthesis and enterohepatic circulation 0.7583141257820109 1.3890871717636422 0.1648062441290001 1.0 0.5202447213625817 2 P27361 1 |
| Il17 signaling pathway 0.839179078378226 1.3865729484220768 0.1655720218741885 1.0 0.5202447213625817 3 P31749 1 |
| Progeriaassociated lipodystrophy 0.6119615437770168 1.3740193926764506 0.1694356620267836 1.0 0.5232368829527076 10 O75844 1 |
| Kennedy pathway from sphingolipids 0.7576583692736658 1.3716408647137288 0.1701752658338904 1.0 0.5232368829527076 4 P35790 1 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.7274008843846549 1.3697681802895638 0.170759277835423 1.0 0.5232368829527076 5 P09601 1 |
| Disruption of postsynaptic signaling by cnv 0.6670873228146122 1.3692967946318155 0.1709065195574171 1.0 0.5232368829527076 7 P27361,Q14168 2 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.6080174786613478 1.3539474478546505 0.1757531443722206 1.0 0.5326123207625164 10 P55210,Q16539,P31749,P63000,P31751,P27361,P35222 7 |
| Omega3 omega6 fatty acid synthesis 0.6847008457084656 1.3508364152072343 0.1767478402146709 1.0 0.532921518223023 6 O15254,O95864 2 |
| Nephrotic syndrome 0.5505466292542388 1.344358543730603 0.178832472695152 1.0 0.5338149309950287 14 O75844,Q14108 2 |
| Hepatitis b infection 0.4649146016410706 1.3363047966192465 0.181449669360052 1.0 0.5362646168710449 24 P31749,P31751,P27361,Q9Y277 4 |
| Influence of laminopathies on wnt signaling 0.5892482448125916 1.3261646969445404 0.1847851500636759 1.0 0.5407683068039928 11 O75844 1 |
| P53 transcriptional gene network 0.585815786313191 1.3081128856543836 0.1908350235183948 1.0 0.5453058610820518 11 Q7LG56,P11166,P04066 3 |
| Head and neck squamous cell carcinoma 0.4888264135764796 1.3073697735059224 0.1910871578341466 1.0 0.5453058610820518 18 P11802,P31749,P54646,Q8N122,P31751,P35222,P62942,Q14145,O00459 9 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5163563442987907 1.306859538059162 0.1912604201240351 1.0 0.5453058610820518 16 P11802,O75844,O60725,P35222,P49354,P50402,P55209,Q9Y2U8,P42167 9 |
| Serotonin and anxiety 0.7388870595982894 1.3028837776464035 0.1926144430644401 1.0 0.5453058610820518 2 Q06787 1 |
| Cardiac hypertrophic response 0.5784049690774058 1.269080720812047 0.2044122756319191 1.0 0.5627885210028049 11 P31749,P27361 2 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.5649944972193387 1.2684792498043655 0.2046268562833852 1.0 0.5627885210028049 12 P31749,P54646,Q8N122,P31751,P27361,O00459 6 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.730694227168126 1.2612039015330856 0.2072353933379918 1.0 0.5627885210028049 4 P31749 1 |
| Allograft rejection 0.6023805067314858 1.260767143601068 0.2073927548084038 1.0 0.5627885210028049 9 P08183,Q9BY49,P08670 3 |
| Copper homeostasis 0.7286394252134342 1.2527869117800603 0.2102832660816833 1.0 0.5632251478345153 4 O75880,P31749 2 |
| Nrf2are regulation 0.6179114341990475 1.236710460537052 0.2161945938052427 1.0 0.5736363222299108 8 P09601 1 |
| Proximal tubule transport 0.5887699978358768 1.1930828626318712 0.2328369224496236 1.0 0.6042907398097843 9 P08183,P11166 2 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.6260920367171882 1.179096698467447 0.2383596731210198 1.0 0.6081227557831147 7 P31749 1 |
| Caloric restriction and aging 0.679530273303232 1.1655664248622095 0.2437897892578751 1.0 0.6167055262158959 5 P43490 1 |
| Oxidative phosphorylation 0.4285111288836195 1.1260048720576767 0.2601634571020224 1.0 0.6358252525593473 30 P24539,P03886,O75964,O43678,O95168,Q86Y39,O75306,Q9Y6M9,P00846 9 |
| Nuclear receptors metapathway 0.3738964013504421 1.1241879240030148 0.2609333113518259 1.0 0.6358252525593473 54 P11802,O00767,Q92504,Q99735,P09601,Q9Y289,Q14145,Q07812,Q14914,Q9H2J7,P11166,Q15067,Q06520,P04150,O15217,P27105,P08183,P23786,P50416,Q15257,Q9HCL2 21 |
| Circadian rhythm genes 0.3856778141967317 1.1210965408543605 0.2622467709512055 1.0 0.6364281392596329 41 Q9BWF3,P54646,Q08211,P23246,Q15233,Q8WXF1,P54802,P00813,P50416,P43490,Q14103 11 |
| Cellular proteostasis 0.6885131672984252 1.088737388042187 0.276269709317499 1.0 0.66038590184045 4 O15212,Q9UHV9 2 |
| Constitutive androstane receptor pathway 0.6061657260938655 1.0864990051287602 0.2772582808307988 1.0 0.66038590184045 7 Q06520,P08183 2 |
| Eicosanoid metabolism via lipooxygenases lox 0.6007175520238154 1.0612028768869848 0.2885977122611287 1.0 0.6751559128467419 7 Q14914,O15254 2 |
| Epo receptor signaling 0.6000885273198333 1.058283374508518 0.2899262702408338 1.0 0.6751559128467419 7 P31749 1 |
| Nad biosynthetic pathways 0.6539574802096259 1.0567077044366586 0.2906450077078939 1.0 0.6751559128467419 5 P43490 1 |
| Amyotrophic lateral sclerosis als 0.5232718570664002 1.0405929953201447 0.2980644835403965 1.0 0.6870443887012229 12 Q07812,Q16539,P63000,O96008,Q9BUN8,P07197,P20339,Q08209 8 |
| Primary focal segmental glomerulosclerosis fsgs 0.4596625162206497 1.0282604174496446 0.3038273451242306 1.0 0.6923088741952889 17 P31749,Q14108 2 |
| Purine metabolism and related disorders 0.4822682361933097 1.0208445405700075 0.3073280981524307 1.0 0.6960810593999895 15 P00813 1 |
| Nad metabolism 0.6678271243473747 1.004689228192888 0.3150465166175342 1.0 0.7006020325934231 4 P43490 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.6413763788049692 1.0033714935090696 0.3156816528771036 1.0 0.7006020325934231 5 Q07954,P35222,P25054 3 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.6394979003963777 0.995425419220434 0.3195294007668137 1.0 0.7030152085194412 5 O60725 1 |
| Apoptosis modulation and signaling 0.47569722564736 0.9809685948117088 0.3266082287939253 1.0 0.7065975055771438 15 Q07812,P55210,O95831,P27361,Q9Y3E5 5 |
| 15q112 copy number variation syndrome 0.6614056600345679 0.9787200274851204 0.3277183336453144 1.0 0.7065975055771438 4 Q06787,Q9BSJ2 2 |
| Neural crest cell migration in cancer 0.5804275458002988 0.9672011836683204 0.3334434705893558 1.0 0.706732440814323 7 P31749 1 |
| Neural crest cell migration during development 0.5804275458002988 0.9672011836683204 0.3334434705893558 1.0 0.706732440814323 7 P31749 1 |
| Camkk2 pathway 0.5314113524131179 0.961275469590617 0.3364136785432592 1.0 0.7071794580645272 10 P09601 1 |
| Tolllike receptor signaling pathway 0.4901931629377735 0.9228649912780515 0.3560775667011242 1.0 0.7411508620460066 13 P31749,P27361 2 |
| Nanomaterial induced apoptosis 0.570728131542529 0.922440878011881 0.3562986556234571 1.0 0.7411508620460066 7 Q07812,P55210,O95831 3 |
| Burn wound healing 0.5328472486127012 0.914560993019866 0.3604221442842923 1.0 0.7471250699226476 9 P31749 1 |
| Cannabinoid receptor signaling 0.6175928335858375 0.9032037611924488 0.3664177620577034 1.0 0.7498782058434289 5 Q8NCG7,Q16539,P27361 3 |
| Vitamin b12 metabolism 0.5847319758878704 0.9031780205662664 0.3664314211074049 1.0 0.7498782058434289 6 Q8WTV0 1 |
| Resistin as a regulator of inflammation 0.5826116138008229 0.8937906278737826 0.3714339245987528 1.0 0.7498782058434289 6 P31749,P27361 2 |
| Wnt signaling pathway 0.5057223682112758 0.8844270949121081 0.3764657019447637 1.0 0.7498782058434289 11 P31749,P25054,Q9BTU6,P63000,P35222,P42345 6 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.7052042160737994 0.866786412783548 0.3860590480836627 1.0 0.7654715589336796 3 P08195,Q14145 2 |
| Fbxl10 enhancement of maperk signaling in diffuse large bcell lymphoma 0.5749183076115023 0.8598165390637148 0.3898901808448216 1.0 0.768199465228906 6 O75530 1 |
| Embryonic stem cell pluripotency pathways 0.4879145239957646 0.8473604015939399 0.3967942690209338 1.0 0.7792308506759786 12 P31749,P31751,P35222,P42345,O00459 5 |
| Fluoroacetic acid toxicity 0.6031134907181246 0.8428081872117349 0.3993357283631253 1.0 0.7816505896156913 5 P51648 1 |
| Il7 signaling pathway 0.5511338370296497 0.8325600002927004 0.405092925946013 1.0 0.7877539960578819 7 P31749 1 |
| Netrinunc5b signaling pathway 0.4943902085322686 0.824716339100632 0.4095326532213028 1.0 0.7900111572569779 11 P31749,P27361 2 |
| Familial hyperlipidemia type 4 0.6936552908393818 0.8235002958748469 0.4102235489944106 1.0 0.7900111572569779 3 Q9UBV2 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.4591654259022114 0.8110273034411423 0.4173499913184582 1.0 0.8011509479650146 14 P49748,O43772,Q9BY49,P23786,P50416 5 |
| Oncostatin m signaling pathway 0.4696235988499199 0.8068914723435332 0.4197290123092752 1.0 0.8016134979245894 13 P55210,Q16539,P31749,P24941,P27361 5 |
| Endometrial cancer 0.4582226282399072 0.8055372952385509 0.4205096936487413 1.0 0.8016134979245894 14 Q07812,P31749,P31751,P35222,P27361,O00459 6 |
| Melanoma 0.4138896811005872 0.8036153423295862 0.4216191597124306 1.0 0.8016134979245894 18 P11802,Q07812,P31749,P31751,P27361 5 |
| Extracellular vesiclemediated signaling in recipient cells 0.5919794175066786 0.7967605157016034 0.4255901305315055 1.0 0.8040477944802139 5 P42345,P31749,P35222 3 |
| Follicle stimulating hormone fsh signaling pathway 0.5254503997183306 0.7937392951912855 0.4273472190593514 1.0 0.8040477944802139 8 P31749 1 |
| Pi3kaktmtor vitd3 signaling 0.5885751593429838 0.7827602326273198 0.4337679242607204 1.0 0.8040477944802139 5 P31749 1 |
| Histone modifications 0.4961341226866033 0.7811835425694985 0.4346945517312663 1.0 0.8040477944802139 10 O75530 1 |
| Chromosomal and microsatellite instability in colorectal cancer 0.4104083713915413 0.7802085153181526 0.4352681509388398 1.0 0.8040477944802139 18 P27361,P31749,P31751 3 |
| Micrornas in cardiomyocyte hypertrophy 0.3992280483327002 0.7787894932562616 0.4361037279271007 1.0 0.8040477944802139 19 Q16539,P31749,P31751,Q13144,P27361,P35222,Q08209,O00459 8 |
| Notch signaling pathway 0.5050445388313143 0.7772511412021191 0.4370106149029384 1.0 0.8040477944802139 9 Q92542 1 |
| Tnfalpha signaling pathway 0.385799176514315 0.763770620967152 0.445003947427165 1.0 0.8094825061212716 20 Q07812,P55210,P31749,P27361,Q6GQQ9 5 |
| Fatty acid betaoxidation 0.3856792392100621 0.7629007979878495 0.445522560276828 1.0 0.8094825061212716 20 P23786,Q96AD5,P49748,O43772 4 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.5810567038346317 0.751984904831971 0.4520601366347132 1.0 0.8094825061212716 5 P31749,Q8N122,O00459 3 |
| Small cell lung cancer 0.4489114847109925 0.7514362199667345 0.4523901715714726 1.0 0.8094825061212716 14 Q07812,P11802,P31749,P24941,P31751 5 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3763188519382701 0.7505460868881809 0.4529258777062497 1.0 0.8094825061212716 32 Q8WTV0,P31749,P37268,Q14534,Q16850,P14324 6 |
| 16p112 distal deletion syndrome 0.5328347485185749 0.7495382161804646 0.4535328736985407 1.0 0.8094825061212716 7 Q9H2V7 1 |
| Serotonin receptor 467 and nr3c signaling 0.6026509777450888 0.7455495877121747 0.4559395456057942 1.0 0.810106871210295 4 P27361 1 |
| Estrogen receptor pathway 0.6702124640101227 0.737067997165987 0.4610809996677756 1.0 0.816159844898629 3 Q15067 1 |
| Interleukin11 signaling pathway 0.4560647254258654 0.7309418830173655 0.4648146520360701 1.0 0.816159844898629 13 P31749,P27361 2 |
| Eicosanoid metabolism via cyclooxygenases cox 0.5251292518721095 0.7149265149548776 0.4746544520077855 1.0 0.8237462437460696 7 Q14914,O15254 2 |
| Vitamin d in inflammatory diseases 0.5938575279177629 0.7116225529593073 0.4766985374982866 1.0 0.8248957301057308 4 Q16539,P04150 2 |
| Il6 signaling pathway 0.4768556137861863 0.6840830223656514 0.4939227419115286 1.0 0.8355693180595138 10 P31749 1 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.4670463678461442 0.6820046713352703 0.4952359970694315 1.0 0.8355693180595138 11 P31749,P27361 2 |
| Nrf2 pathway 0.3747411153926788 0.6612798410056525 0.5084328670404652 1.0 0.8522179305482511 24 Q14145,Q14914,Q92504,P09601 4 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.5282822701722425 0.6579297577996698 0.5105832680065834 1.0 0.8522179305482511 6 Q07812,P55210,P31749 3 |
| Pi3kakt signaling pathway 0.3476618874854949 0.6527766801481593 0.5139002596270861 1.0 0.8522179305482511 38 P11802,Q16537,P63151,P54646,P31749,Q8N122,P24941,P63000,Q16822,P31751,P27361,Q9UBI6,P30154,P30153,Q16543,P42345,O00459 17 |
| Wnt signaling pathway and pluripotency 0.4293468728139966 0.6387215234358208 0.5230041082666002 1.0 0.8582943452944368 14 Q16537,P63151,P25054,P35222,P30154,Q15257 6 |
| Nocgmppkg mediated neuroprotection 0.5522444322131068 0.6362484285002317 0.5246145126631263 1.0 0.8582943452944368 5 P30536 1 |
| Robo4 and vegf signaling pathways crosstalk 0.5818241685874138 0.6355888610055509 0.5250444316052838 1.0 0.8582943452944368 2 P63000 1 |
| Mevalonate pathway 0.5209949370120525 0.6272375385553568 0.5305035400563605 1.0 0.8582943452944368 6 P14324 1 |
| Steroid biosynthesis 0.5755679947316401 0.6114503916460293 0.5409014507875558 1.0 0.8647960079356543 2 Q99829 1 |
| Onecarbon metabolism and related pathways 0.4323074355729266 0.5995403465766228 0.5488126133946571 1.0 0.8690746159061281 13 P35790,O43865 2 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.4557984186618283 0.5798541661314479 0.5620129664672775 1.0 0.8808216327130698 10 Q9BWD1,P14324 2 |
| Wnt signaling in kidney disease 0.5498847546921198 0.5158503370480345 0.6059589424515177 1.0 0.9252224446629848 2 P35222 1 |
| Chemokine signaling pathway 0.3487867147593246 0.4986462818364826 0.6180285942778239 1.0 0.9252224446629848 20 P31749,P31751,P27361 3 |
| Tgfbeta receptor signaling 0.5156019706353133 0.4957855152476583 0.6200457454249046 1.0 0.9252224446629848 5 P62942,P27361 2 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.5156019706353133 0.4957855152476583 0.6200457454249046 1.0 0.9252224446629848 5 P62942,P27361 2 |
| Folate metabolism 0.4024907409259965 0.4873927631629467 0.625980021037396 1.0 0.9252224446629848 14 Q8WTV0,P00374,Q8NFF5 3 |
| Vitamin dsensitive calcium signaling in depression 0.4849983514672074 0.4805693589640047 0.6308225971064416 1.0 0.9252224446629848 6 P20020,P48506,P11413,O60341,Q8NB78 5 |
| Epithelial to mesenchymal transition in colorectal cancer 0.3545010605813976 0.4714481961130211 0.6373207053151551 1.0 0.9252224446629848 19 O75530,P31749,P27361 3 |
| Tryptophan metabolism 0.4083726556909179 0.4705456035364743 0.6379652607584458 1.0 0.9252224446629848 13 P51648,Q15392,P05091 3 |
| Glycerophospholipid biosynthetic pathway 0.4676688445211659 0.4668072042980388 0.6406378210291492 1.0 0.9252224446629848 7 O00116,Q9BTU6 2 |
| Riboflavin and coq disorders 0.5064592395729121 0.4622491404109886 0.6439026673867507 1.0 0.9252224446629848 5 Q16134 1 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.3978347476769753 0.4617176908742634 0.6442837829132011 1.0 0.9252224446629848 14 P43490,Q8IXJ6 2 |
| Preimplantation embryo 0.4662396951661102 0.4609331945499809 0.6448465354186097 1.0 0.9252224446629848 7 Q99729,P05023 2 |
| Iron metabolism in placenta 0.5330918669739833 0.4568057257885117 0.6478106898980363 1.0 0.9252224446629848 2 P21399 1 |
| Selenium micronutrient network 0.4198449497882648 0.4443935035901734 0.6567581094578914 1.0 0.9313173191124968 11 Q8WTV0,Q8NFF5 2 |
| Nonsmall cell lung cancer 0.3569183309141844 0.4279451058873207 0.6686910866047511 1.0 0.943755505208124 18 Q07812,P11802,P31749,P31751,P27361,O00459 6 |
| Thermogenesis 0.3424905276916276 0.4200993558384445 0.6744128732528183 1.0 0.9451278998402172 29 Q16539,P54646,O43772,Q96GM5,Q8TAQ2,P23786,Q96AD5,Q9UKU0,P50416 9 |
| Il5 signaling pathway 0.4103597006268441 0.3987649796718888 0.6900663834893752 1.0 0.9536334049610116 11 P31749 1 |
| Glycogen synthesis and degradation 0.3584994347104988 0.3831514452688098 0.7016074769259681 1.0 0.9580832241532136 17 Q16537,P52789,P46976,Q15257 4 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.4520276953511396 0.3557368443826236 0.7220376497726007 1.0 0.9700969369170804 6 P04150,P61201,P06753,P18031,P06730 5 |
| Ppar signaling pathway 0.3351465869388741 0.3439430251651501 0.7308891341411718 1.0 0.9700969369170804 19 O00767,Q15067,P23786,P22307,Q9UKU0,O15254,O95864,P50416 8 |
| Ebola virus infection in host 0.3216527371738909 0.3347042107152141 0.7378482247952403 1.0 0.9700969369170804 34 P31749,P27361,P05198,Q9P253,O15118 5 |
| Pancreatic adenocarcinoma pathway 0.3271805216545116 0.3231090572402375 0.7466126511712197 1.0 0.9700969369170804 23 P11802,Q07812,P31749,P31751,P27361,O00459 6 |
| Glial cell differentiation 0.4840302930523439 0.3036384200216767 0.7614033777168572 1.0 0.9700969369170804 2 P26038 1 |
| Nanoparticle triggered regulated necrosis 0.4837010207441569 0.3027203948536309 0.7621029537924802 1.0 0.9700969369170804 2 Q13546 1 |
| Ciliary landscape 0.2895096726657368 0.2900911332895508 0.7717465189013804 1.0 0.971377292190184 103 P08670,P27105,P16278,P10619,Q14566,O15173,O43805,P06280 8 |
| Genes related to primary cilium development based on crispr 0.3722748311164641 0.2864957116107069 0.7744984775251718 1.0 0.971377292190184 13 O95684 1 |
| 3q29 copy number variation syndrome 0.3630401266151744 0.2774938193410326 0.7814009510069113 1.0 0.9779798066061344 14 O95684 1 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.4168865435356257 0.2710823996441777 0.786327657979162 1.0 0.9800367678779952 7 P05556,P35222,Q13177,Q16512,Q13043,P27348 6 |
| Purinergic signaling 0.4678959499505992 0.2605497365761103 0.794439755411654 1.0 0.9843133347820876 2 P08754 1 |
| Acute viral myocarditis 0.3636665515668614 0.2451801830355301 0.8063169198264792 1.0 0.9899073183779036 13 Q07812,P31749,P27361 3 |
| Neuroinflammation and glutamatergic signaling 0.3128881959594924 0.2447270545810671 0.806667778376501 1.0 0.9899073183779036 21 P31749,P34897,P27361,Q96QD8,Q13555,P11166 6 |
| Endochondral ossification 0.4090299008485374 0.2436365283213669 0.8075123350921927 1.0 0.9899073183779036 7 P31749 1 |
| Endochondral ossification with skeletal dysplasias 0.4090299008485374 0.2436365283213669 0.8075123350921927 1.0 0.9899073183779036 7 P31749 1 |
| Orexin receptor pathway 0.3395418049944564 0.2307772967092253 0.8174878197833584 1.0 0.9922804813005892 16 P27361,Q13595,O60313,P11166,Q9H4L5,P11177,O00459 7 |
| Supression of hmgb1 mediated inflammation by thbd 0.451432334540651 0.2207050359850134 0.8253221100053945 1.0 0.9922804813005892 2 P09429 1 |
| Pilocytic astrocytoma 0.4511030622324518 0.2199518212551223 0.8259086768711132 1.0 0.9922804813005892 2 P62993 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3361431837038289 0.2126575105070874 0.8315941103541205 1.0 0.9922804813005892 16 Q14739,P27361 2 |
| Proteasome degradation 0.2896095617514701 0.2056074692946413 0.8370975425341829 1.0 0.9922804813005892 41 P04843,P28072,P49721,P28070,P46934,Q9UL46,P20618,P60900,O00231,P28074 10 |
| Omega9 fatty acid synthesis 0.4029895257054787 0.1938637668268377 0.8462825552983595 1.0 0.9922804813005892 6 O95864 1 |
| Egfr tyrosine kinase inhibitor resistance 0.325337199521201 0.1919096635316418 0.8478129677378998 1.0 0.9922804813005892 17 P31749,P27361 2 |
| Translation inhibitors in chronically activated pdgfra cells 0.3106261231443134 0.1911637373765484 0.8483973130399354 1.0 0.9922804813005892 19 P31749,P27361 2 |
| Pdgf pathway 0.3619961055273024 0.183689757572723 0.8542568444582033 1.0 0.9922804813005892 11 P00403 1 |
| Regucalcin in proximal tubule epithelial kidney cells 0.3862085283004686 0.1691914025564018 0.8656460920693456 1.0 0.9922804813005892 7 Q07812,Q8NE86,P31749 3 |
| Glucocorticoid receptor pathway 0.3929869963663756 0.1651441442641046 0.8688305278955102 1.0 0.9922804813005892 6 P27105 1 |
| Mthfr deficiency 0.3834253316306899 0.16068782548448 0.872339278680031 1.0 0.9922804813005892 7 P35790 1 |
| Serine metabolism 0.3829275844954927 0.1591808771909253 0.8735263695476088 1.0 0.9922804813005892 7 P00374,P34897 2 |
| Cytosolic dnasensing pathway 0.3413747521480409 0.144209056712065 0.885335389479982 1.0 1.0 13 P52434,Q9BUI4,O15111,P19388,Q86UT6,O15160,Q9NZI8,P55265,Q7Z434,Q13546,P62875,Q14258 12 |
| Male infertility 0.2963907980051178 0.1297978255213181 0.8967263833442878 1.0 1.0 22 Q15165 1 |
| Hippo signaling regulation pathways 0.3302479338842862 0.121289559938553 0.9034616889307832 1.0 1.0 14 P08754,P54646,P60953,P63000,P19022,P35222,P04899,P13861,P17612,P10644,Q13043,P54619,P42345 13 |
| Calcium regulation in cardiac cells 0.291337628523379 0.1205886683478879 0.9040168446880212 1.0 1.0 20 P20020,Q04917,P16615,Q9UBI6,P62258,P62942,Q13555,P10644 8 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.3351441409499341 0.117751825710106 0.9062643014061038 1.0 1.0 13 P55010 1 |
| Il1 signaling pathway 0.3371234655853424 0.1049722435699212 0.916397833433398 1.0 1.0 12 P61088,P31749,P27361,O00459 4 |
| Signal transduction through il1r 0.3773895847066624 0.0910083992942394 0.9274859170837866 1.0 1.0 5 Q16539,Q15750,O15111,Q9BQ95 4 |
| Vitamin b12 disorders 0.4189723320158063 0.082249347705385 0.9344484325510028 1.0 1.0 3 Q99707,Q96EY8 2 |
| Leukocyteintrinsic hippo pathway functions 0.3590504451038534 0.0802567657453233 0.9360330431820768 1.0 1.0 6 Q16539,Q92597,P63000,Q13043,P27348 5 |
| Genes controlling nephrogenesis 0.3756177924217503 0.0797447159518235 0.9364402944864968 1.0 1.0 4 P05556,P35222,O94813 3 |
| Tcell activation sarscov2 0.3137024178111069 0.0741618203222391 0.9408816251273906 1.0 1.0 15 P31749 1 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.3623170337162258 0.0634946678791557 0.9493726050943908 1.0 1.0 5 Q13555,P27361 2 |
| Angiopoietinlike protein 8 regulatory pathway 0.2893235287159272 0.0633171858343623 0.94951393090495 1.0 1.0 32 Q14254,Q16539,O00767,P54646,P31749,P31751,P27361,Q15642,O75955,P11166,O00459 11 |
| Physiological and pathological hypertrophy of the heart 0.3615688859591355 0.0622244979003227 0.9503840537846316 1.0 1.0 5 Q16539,P63000,Q08209,P40763 4 |
| Mirnas involvement in the immune response in sepsis 0.3992094861660112 0.061383061746525 0.951054141688258 1.0 1.0 3 Q16539,O15111 2 |
| Hair follicle development cytodifferentiation part 3 of 3 0.3861329873196255 0.0499926550089266 0.9601282414583144 1.0 1.0 3 P04150 1 |
| 1q211 copy number variation syndrome 0.3359269712910141 0.0464949390740979 0.962915767759742 1.0 1.0 8 Q9NPH0,P54646 2 |
| Hippoyap signaling pathway 0.3659420289855102 0.0358285624967609 0.9714190581041636 1.0 1.0 3 Q13043,P27348 2 |
| Disorders of folate metabolism and transport 0.3315194081623456 0.0354279465452576 0.9717385005744444 1.0 1.0 8 P00374,P34897 2 |
| Agerage pathway 0.3016816430815368 0.022998204212481 0.981651705402296 1.0 1.0 15 P31749 1 |
| Gdnfret signaling axis 0.3046772068511263 0.0126012464762572 0.9899459260738608 1.0 1.0 3 P35222,O94813 2 |
|
|
